Title

Tumor Lysis, Adverse Events, and Dose Adjustments in 297 Venetoclax-Treated CLL Patient in Routine Clinical Practice.

Authors

Lindsey E Roeker
Christopher P Fox
Toby A Eyre
Danielle M Brander
John N Allan
Stephen J Schuster
Chadi Nabhan
Brian T Hill
Nirav N Shah
Frederick Lansigan
Maryam Yazdy
Bruce D Cheson
Nicole Lamanna
Arun K Singavi
Catherine C Coombs
Paul M Barr
Alan P Skarbnik
Mazyar Shadman
Chaitra S Ujjani
Hande H Tuncer
Allison M Winter
Joanna Rhodes
Colleen Dorsey
Hannah Morse
Charlene Kabel
John M Pagel, SWEDISH CANCER INSTITUTE.Follow
Annalynn M Williams
Ryan Jacobs
Andre Goy
Sivraj Muralikrishnan
Laurie Pearson
Andrea Sitlinger
Neil Bailey
Anna Schuh
Amy A Kirkwood
Anthony R Mato

Document Type

Article

Publication Date

4-19-2019

Publication Title

Clinical cancer research : an official journal of the American Association for Cancer Research

Clinical Institute

Cancer

Department

Oncology

Recommended Citation

Roeker, Lindsey E; Fox, Christopher P; Eyre, Toby A; Brander, Danielle M; Allan, John N; Schuster, Stephen J; Nabhan, Chadi; Hill, Brian T; Shah, Nirav N; Lansigan, Frederick; Yazdy, Maryam; Cheson, Bruce D; Lamanna, Nicole; Singavi, Arun K; Coombs, Catherine C; Barr, Paul M; Skarbnik, Alan P; Shadman, Mazyar; Ujjani, Chaitra S; Tuncer, Hande H; Winter, Allison M; Rhodes, Joanna; Dorsey, Colleen; Morse, Hannah; Kabel, Charlene; Pagel, John M; Williams, Annalynn M; Jacobs, Ryan; Goy, Andre; Muralikrishnan, Sivraj; Pearson, Laurie; Sitlinger, Andrea; Bailey, Neil; Schuh, Anna; Kirkwood, Amy A; and Mato, Anthony R, "Tumor Lysis, Adverse Events, and Dose Adjustments in 297 Venetoclax-Treated CLL Patient in Routine Clinical Practice." (2019). Articles, Abstracts, and Reports. 1413.
https://digitalcommons.providence.org/publications/1413